Mark Enthoven

Title: Mark Enthoven: Innovator in Pharmaceutical Science

Introduction

Mark Enthoven is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of pharmaceutical science, particularly in the development of FSH receptor antagonists. With a total of three patents to his name, Enthoven's work has the potential to impact various medical treatments.

Latest Patents

Enthoven's latest patents focus on FSH receptor antagonists, which are compounds that can be used for the treatment and prevention of endometriosis. These inventions also target pre-menopausal and peri-menopausal hormone-dependent breast cancer, contraception, and the treatment of uterine fibroids and other menstrual-related disorders. The compounds are described by a general formula and can be formulated into pharmaceutical compositions for effective use.

Career Highlights

Mark Enthoven is currently associated with Merck Sharp & Dohme B.V., a leading global healthcare company. His work at Merck has allowed him to further his research and development efforts in innovative pharmaceutical solutions. Enthoven's dedication to advancing medical science is evident through his patent filings and ongoing research.

Collaborations

Enthoven has collaborated with notable colleagues such as Wesley Peter Blackaby and Martin De Kort. These partnerships have likely contributed to the success of his research and the development of his patented inventions.

Conclusion

Mark Enthoven stands out as an influential inventor in the pharmaceutical industry. His work on FSH receptor antagonists showcases his commitment to improving healthcare outcomes. Through his patents and collaborations, Enthoven continues to make strides in medical innovation.